Advanced Drainage Systems (WMS) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
5 Feb, 2026Executive summary
Net sales for Q3 FY26 rose 0.4% year-over-year to $693.4 million, with net income up 14.3% to $94.0 million and diluted EPS up 14.4% to $1.19.
Adjusted EBITDA for Q3 grew 9.3% to $209.2 million, with margin improving by 250 basis points to 30.2% on favorable mix and pricing.
Year-to-date net sales increased 3.7% to $2.4 billion, net income up 5.0% to $394.6 million, and diluted EPS up 5.2% to $5.02.
Allied Products and Infiltrator segments drove growth, supported by new products, expanded distribution, and acquisitions.
Completed the NDS acquisition, expanding the product portfolio and distribution channels.
Financial highlights
Q3 gross profit increased 7.3% to $259.2 million, with gross margin at 37.4%; year-to-date gross profit rose 7.1% to $929.7 million, with margin at 39.2%.
Year-to-date Adjusted EBITDA was $774.9 million, up 8.8%, with margin at 32.6%.
Free cash flow for the nine months was $582.4 million, and net cash from operations was $779.1 million.
Ended the quarter with $1.0 billion in cash and total liquidity of $1.6 billion.
Net leverage at 0.5x as of December 31, 2025, and 1.5x post-NDS acquisition.
Outlook and guidance
FY26 net sales guidance raised to $2.99–$3.04 billion; Adjusted EBITDA guidance increased to $930–$960 million, with margin expected at 31.1–31.6%.
Guidance includes $40 million in revenue and a 20% EBITDA margin from NDS for the remainder of the fiscal year.
Capital expenditures projected at approximately $250 million for FY26.
Fourth quarter expected to be variable due to weather impacts and macroeconomic uncertainty.
Sufficient liquidity is expected to meet obligations for at least the next twelve months.
Latest events from Advanced Drainage Systems
- Q1 sales up 4.8% to $815M; margin strong at 33.8%, but net income down 6.7%.WMS
Q1 20259 Jul 2026 - Net sales up 4.3% in Q3 FY25, but net income and margins declined amid higher costs.WMS
Q3 20258 Jul 2026 - FY25 net sales up 1% to $2.90B, with margin pressure and cautious FY26 outlook.WMS
Q4 20258 Jul 2026 - Flat Q2 sales, resilient margins, profit down; FY25 outlook reflects Orenco acquisition, cost pressures.WMS
Q2 20258 Jul 2026 - Targeting >8% organic CAGR and >$1.2B EBITDA by FY30 through innovation and disciplined capital deployment.WMS
Investor Day 202619 Jun 2026 - Strong financial results, performance-based executive pay, and enhanced ESG initiatives highlighted.WMS
Proxy filing3 Jun 2026 - Votes will be held on directors, auditor ratification, and executive compensation.WMS
Proxy filing3 Jun 2026 - Strong FY26 growth from acquisitions and product mix; FY27 outlook sees sales up but margins tighter.WMS
Q4 202621 May 2026 - Record profitability, strong ESG progress, and performance-based executive pay define FY2024.WMS
Proxy Filing1 Dec 2025